Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Revenues:        
Revenues $ 1,803,773 $ 1,423,964 $ 4,993,263 $ 4,346,831
Costs and expenses:        
Costs of revenues 709,629 590,158 1,999,924 1,828,017
Research and development 238,957 215,433 687,059 646,764
Selling, general and administrative 183,040 185,760 537,580 566,358
Goodwill impairment 0 256,649 0 256,649
Interest expense 39,092 39,231 117,358 120,053
Loss on extinguishment of debt 0 22,538 0 22,538
Other expense (income), net (7,348) (1,004) (269) (5,190)
Income before income taxes 640,403 115,199 1,651,611 911,642
Provision for income taxes 73,233 37,190 207,316 106,932
Net income 567,170 78,009 1,444,295 804,710
Less: Net loss attributable to non-controlling interest (326) (443) (1,019) (822)
Net income attributable to KLA $ 567,496 $ 78,452 $ 1,445,314 $ 805,532
Net income per share attributable to KLA        
Basic (in dollars per share) $ 3.69 $ 0.50 $ 9.36 $ 5.12
Diluted (in dollars per share) $ 3.66 $ 0.50 $ 9.28 $ 5.08
Weighted-average number of shares:        
Basic (in shares) 153,801 156,067 154,457 157,356
Diluted (in shares) 155,159 157,172 155,789 158,586
Product        
Revenues:        
Revenues $ 1,375,320 $ 1,051,096 $ 3,758,838 $ 3,253,621
Service        
Revenues:        
Revenues $ 428,453 $ 372,868 $ 1,234,425 $ 1,093,210